Archimica has started the operation of its expanded development laboratories at its Lodi (Italy) site. This recent $1.6 Million investment has more than doubled the company's capabilities to realize API and GMP Building Block custom process development and manufacturing projects from April 2021 on.
“With this expansion, our integrated process development and manufacturing team can use significantly expanded laboratory capacity applying Archimica´s unique chemical technology portfolio to the benefit of our customers worldwide. Archimica’s broad permit and state-of-the-art environmental protection facilities enable us to industrialize products and processes with the most challenging reagents and reactions known”, said Ralf Pfirmann, Executive Chairman of Archimica.
About Archimica
Archimica is a leading organization specialized for more than 70 years in active pharmaceutical ingredients (APIs) development and manufacture for the benefit of customers and patients worldwide.
Archimica offers a range of standard care generic APIs in a broad range of therapeutic areas as well as custom synthesis of late-stage intermediates and APIs for the innovative and generic pharmaceutical industry. Its offering covers a highly flexible, agile small clinical stage to continuously improving large commercial manufacturing as well as process development, analytical, quality and regulatory services.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!